Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization.
作者信息
Jeong Soung Won
机构信息
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
出版信息
Ann Transl Med. 2020 Sep;8(18):1124. doi: 10.21037/atm-20-4296.
Abstract
摘要
相似文献
1
Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization.中性粒细胞与淋巴细胞比值作为经动脉化疗栓塞术后肝细胞癌预后生物标志物的研究
Ann Transl Med. 2020 Sep;8(18):1124. doi: 10.21037/atm-20-4296.
2
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma.中性粒细胞-淋巴细胞比值预测可切除肝细胞癌患者新辅助经动脉化疗栓塞的治疗获益。
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1186-1191. doi: 10.1097/MEG.0000000000001629.
3
The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合应用于接受经动脉化疗栓塞治疗的肝细胞癌患者的预后及预测价值。
Cancer Manag Res. 2019 Feb 12;11:1391-1400. doi: 10.2147/CMAR.S190545. eCollection 2019.
4
Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.中性粒细胞与载脂蛋白A1比值可预测接受经动脉化疗栓塞术的肝细胞癌患者的总生存期。
Oncologist. 2021 Aug;26(8):e1434-e1444. doi: 10.1002/onco.13743. Epub 2021 Mar 24.
5
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.经动脉化疗栓塞术联合仑伐替尼对比经动脉化疗栓塞术联合索拉非尼作为伴门静脉癌栓的肝细胞癌一线治疗的前瞻性随机研究。
Cancer. 2021 Oct 15;127(20):3782-3793. doi: 10.1002/cncr.33677. Epub 2021 Jul 8.
6
The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.中性粒细胞与淋巴细胞比值是接受经动脉化疗栓塞的肝细胞癌患者生存的一个预测因素。
Ann Transl Med. 2020 Apr;8(8):541. doi: 10.21037/atm.2020.02.113.
7
Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study.接受经动脉化疗栓塞和放射性栓塞的肝细胞癌患者的预后因素：一项回顾性研究。
Eur J Gastroenterol Hepatol. 2020 Aug;32(8):1036-1041. doi: 10.1097/MEG.0000000000001625.
8
Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.血清微小RNA-210作为接受经动脉化疗栓塞的肝细胞癌患者治疗反应和预后的预测生物标志物。
J Vasc Interv Radiol. 2014 Aug;25(8):1279-1287.e1. doi: 10.1016/j.jvir.2014.04.013. Epub 2014 Jun 13.
9
Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.衍生中性粒细胞与淋巴细胞比值可预测经动脉化疗栓塞术后乙肝相关肝细胞癌患者的预后。
Oncol Lett. 2016 May;11(5):2987-2994. doi: 10.3892/ol.2016.4359. Epub 2016 Mar 21.
10
Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis.经动脉化疗栓塞术与索拉非尼联合应用可改善不可切除肝细胞癌的预后：一项更新的系统评价和荟萃分析。
Jpn J Clin Oncol. 2018 Dec 1;48(12):1058-1069. doi: 10.1093/jjco/hyy138.
本文引用的文献
1
The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.中性粒细胞与淋巴细胞比值是接受经动脉化疗栓塞的肝细胞癌患者生存的一个预测因素。
Ann Transl Med. 2020 Apr;8(8):541. doi: 10.21037/atm.2020.02.113.
2
Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC.术前中性粒细胞与淋巴细胞比值（NLR）和血小板与淋巴细胞比值（PLR）作为可切除肝癌预后不良的指标。
PeerJ. 2019 Oct 14;7:e7132. doi: 10.7717/peerj.7132. eCollection 2019.
3
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.甲胎蛋白/白蛋白和中性粒细胞与淋巴细胞比值对接受 TACE 和 RFA 治疗的肝细胞癌患者的预后意义。
J Clin Lab Anal. 2019 Nov;33(9):e22999. doi: 10.1002/jcla.22999. Epub 2019 Aug 16.
4
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea.韩国经动脉化疗栓塞耐药性的调查及肝细胞癌的真实世界治疗模式。
Clin Mol Hepatol. 2020 Jan;26(1):24-32. doi: 10.3350/cmh.2018.0065. Epub 2019 May 20.
5
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.一种包含中性粒细胞与淋巴细胞比值的新列线图的开发，用于预测接受经动脉化疗栓塞的肝细胞癌患者的生存情况。
Cancers (Basel). 2019 Apr 10;11(4):509. doi: 10.3390/cancers11040509.
6
The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合应用于接受经动脉化疗栓塞治疗的肝细胞癌患者的预后及预测价值。
Cancer Manag Res. 2019 Feb 12;11:1391-1400. doi: 10.2147/CMAR.S190545. eCollection 2019.
7
Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization.经动脉化疗栓塞治疗的肝细胞癌患者肿瘤复发和生存的预测因素
J Gastrointestin Liver Dis. 2018 Dec;27(4):409-417. doi: 10.15403/jgld.2014.1121.274.fcr.
8
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
9
Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.射频消融术后局部晚期肝细胞癌患者的消融前中性粒细胞与淋巴细胞比值作为独立预后因素
J Cancer Res Ther. 2018 Jan;14(1):84-89. doi: 10.4103/jcrt.JCRT_835_17.
10
Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值联合作为肝细胞癌射频消融术后复发的有效预测指标。
Oncol Lett. 2018 Jan;15(1):315-323. doi: 10.3892/ol.2017.7291. Epub 2017 Oct 30.
Zotero 插件